Genetic Technologies Limited appointed Carl Stubbings to the role of Chief Commercial Officer. Carl rounds out the leadership team for GTG with considerable experience commercialising diagnostic bproducts. Based in the USA for 13 years, he served as Senior Vice President for Panbio USA Ltd. and Vice-President of Sales and Marketing for Focus Diagnostics, a subsidiary of Quest Diagnostics, one of the world’s large pathology laboratories. More recently he was Chief Operating Officer of ASX listed BARD1 Life Sciences having successfully facilitated the merger with Sienna Cancer Diagnostics as its CEO and Managing Director.